부산대학교 도서관

Aldaz P; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Ausin K; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Wellbrock C; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Department of Health Sciences, Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Santamaria E; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Fernandez-Irigoyen J; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Arozarena I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE

Rowling EJ; Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Miskolczi Z; Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Nagaraju R; Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Wilcock DJ; Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Wang P; Bioinformatics Core Facility, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Telfer B; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Li Y; Division of Molecular and Cellular Function, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Lasheras-Otero I; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Redondo-Muñoz M; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Sharrocks AD; Division of Molecular and Cellular Function, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Arozarena I; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Wellbrock C; Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE

Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Rodriguez-Baena FJ; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain.; Aldaz P; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Moncho-Amor V; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain.; Otaegi-Ugartemendia M; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; Carrasco-Garcia E; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), Madrid, Spain.; Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Santamaria E; Hepatology Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.; Bocanegra A; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Chocarro L; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Grier A; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Dzieciatkowska M M; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Bigas C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Martin J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Urdiroz-Urricelqui U; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Marzo F; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Santamaria E; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Kochan G; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Escors D; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain.; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Larrayoz IM; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain.; Unidad Predepartamental de Enfermería, Universidad de La Rioja (UR), Logroño, Spain.; Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; D'Alessandro A; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Matheu A; Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.; Wellbrock C; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Department of Health Sciences, Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Benitah SA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. salvador.aznar-benitah@irbbarcelona.org.; Sanchez-Laorden B; Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain. berta.lopez@umh.es.; Arozarena I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain. iarozarm@navarra.es.; Health Research Institute of Navarre (IdiSNA), Pamplona, Spain. iarozarm@navarra.es.

Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE

Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Feliu I; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain.; Maillo A; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.; Moreno H; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain.; Redondo-Muñoz M; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Aldaz P; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Bocanegra A; Oncoimmunology Group, Navarrabiomed, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.; Olias-Arjona A; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Lecanda F; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Fernandez-Irigoyen J; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Proteomics Platform, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.; Santamaria E; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Clinical Neuroproteomics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.; Larrayoz IM; Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, Logroño, Spain; Pre-departmental Nursing Unit, University of La Rioja (UR), Logroño, La Rioja, Spain.; Gomez-Cabrero D; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Translational Bioinformatics Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.; Wellbrock C; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain.; Vicent S; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; Program in Solid Tumors, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain; Center for Biomedical Research Network on Cancer (CIBERONC), Madrid, Spain.; Arozarena I; Cancer Signaling Unit, Navarrabiomed, University Hospital of Navarra (HUN), Public University of Navarra (UPNA), Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: iarozarm@navarra.es.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Hendricks JM; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Doubravsky CE; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Wehri E; The Henry Wheeler Center for Emerging and Neglected Diseases, University of California, Berkeley, Berkeley, CA 94720, USA.; Li Z; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Roberts MA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Deol KK; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Lange M; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Lasheras-Otero I; Cancer Signaling Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.; Momper JD; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.; Dixon SJ; Department of Biology, Stanford University, Stanford, CA 94305, USA.; Bersuker K; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.; Schaletzky J; The Henry Wheeler Center for Emerging and Neglected Diseases, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address: jschaletzky@berkeley.edu.; Olzmann JA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA; Miller Institute for Basic Research in Science, University of California, Berkeley, Berkeley, CA 94720, USA; Chan Zuckerberg Biohub - San Francisco, San Francisco, CA 94158, USA. Electronic address: olzmann@berkeley.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

Aldaz P; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Auzmendi-Iriarte J; Cellular Oncology Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; Durántez M; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Lasheras-Otero I; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Carrasco-Garcia E; Cellular Oncology Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, Spain.; Zelaya MV; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Pathological Anatomy Department, CHN, IdiSNA, 31008 Pamplona, Spain.; Bragado L; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Department of Radiophysics and Radiological Protection, CHN, 31008 Pamplona, Spain.; Olías-Arjona A; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Egaña L; Cellular Oncology Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; Biodonostia University Hospital, 20014 San Sebastian, Spain.; Samprón N; Cellular Oncology Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; Biodonostia University Hospital, 20014 San Sebastian, Spain.; Morilla I; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Department of Oncology, CHN, IdiSNA, 31008 Pamplona, Spain.; Redondo-Muñoz M; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Rico M; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Radiotherapy Oncology Department, CHN, 31008 Pamplona, Spain.; Squatrito M; Seve-Ballesteros Foundation Brain Tumor Group, Cancer Cell Biology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Maria-Alonso M; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Program in Solid Tumours and Biomarkers, Foundation for Applied Medical Research, 31008 Pamplona, Spain.; Department of Pediatrics, University Hospital of Navarre, 31008 Pamplona, Spain.; Fernández-Irigoyen J; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, CHN, UPNA, IdiSNA, 31008 Pamplona, Spain.; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, CHN, UPNA, IdiSNA, 31008 Pamplona, Spain.; Santamaria E; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Clinical Neuroproteomics Unit, Navarrabiomed, CHN, UPNA, IdiSNA, 31008 Pamplona, Spain.; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, CHN, UPNA, IdiSNA, 31008 Pamplona, Spain.; Larráyoz IM; Center for Biomedical Research of La Rioja (CIBIR), Neurodegeneration Area, Biomarkers and Molecular Signaling Group, 26006 Logroño, Spain.; Wellbrock C; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.; Matheu A; Cellular Oncology Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, Spain.; IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain.; Arozarena I; Cancer Signalling Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), 31008 Pamplona, Spain.; Health Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE